Public Health

WASHINGTON (AP) — The National Institutes of Health is launching research to understand the causes and consequences of the lingering brain fog, breathing problems and malaise reported by many recovering COVID-19 patients.

Dr. Anthony Fauci says some studies have shown up to 30% of patients report symptoms that can endure for months, complicating their return to normal routines and work, and plunging many recovering patients into depression.

Fauci noted at a White House coronavirus briefing on Wednesday that work at NIH started this week thanks to more than $1 billion provided by Congress for COVID-related medical research. Government scientists are looking to enlist doctors and research institutions around the country in the effort to learn about “long-haul” COVID-19.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about NIH to launch research into Covid long term effects, plus international roundup
Log in or register to post comments

OPINION: Despite problems, America's vaccine rollout has been among the best in the world

Sun, 2021-02-21 12:52 — mike kraft

America's vaccine rollout has been among the best in the world It hasn't been perfect. It could be a whole lot worse. Dave Lawler Axios

America’s much-maligned vaccine rollout is actually going relatively well, at least compared to other wealthy countries.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about OPINION: Despite problems, America's vaccine rollout has been among the best in the world
Log in or register to post comments

Florida governor DeSantis reverses course, accepts FEMA vaccination sites in minority areas

Sat, 2021-02-20 19:31 — mike kraft

DeSantis reverses course as Florida snags federal vaccine sites The four sites are expected to give a boost to areas that have most struggled to secure vaccines. Politico PRO

TALLAHASSEE — Florida is getting four federally-backed Covid-19 vaccination hubs in largely low-income communities of color, an announcement that comes after Gov. Ron DeSantis initially clashed with the Biden administration over federal vaccine help.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Florida governor DeSantis reverses course, accepts FEMA vaccination sites in minority areas
Log in or register to post comments

Africa reaches 100,000 known COVID-19 deaths despite earlier low rates

Fri, 2021-02-19 11:23 — mike kraft

Africa reaches 100,000 known COVID-19 deaths as danger grows NAIROBI, Kenya (AP) — Africa has surpassed 100,000 confirmed deaths from COVID-19 as the continent praised for its early response to the pandemic now struggles with a dangerous resurgence and... AP NEWS

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Africa reaches 100,000 known COVID-19 deaths despite earlier low rates
Log in or register to post comments

Schools: Is it safe to open schools? Yes, but ...a look at the considerations

Thu, 2021-02-18 13:37 — mike kraft

Is it safe to open schools? Yes, but ... Going back to school is frightening for many teachers and parents, especially with coronavirus rates remaining at high levels and new variants of the coronavirus emerging. And yet the negative consequences of all-remote learning are significant, too. Laura Meckler, Karin Brulliard, Brittany Shammas Washington Post

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Schools: Is it safe to open schools? Yes, but ...a look at the considerations
Log in or register to post comments

ANALYSIS" The need for global access to COVID-19 vaccines: production, affordability, allocation, and deployment

Tue, 2021-02-16 18:26 — mike kraft

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00306-8/fulltext

The COVID-19 pandemic is unlikely to end until there is global roll-out of vaccines that protect against severe disease and preferably drive herd immunity. Regulators in numerous countries have authorised or approved COVID-19 vaccines for human use, with more expected to be licensed in 2021. Yet having licensed vaccines is not enough to achieve global control of COVID-19: they also need to be produced at scale, priced affordably, allocated globally so that they are available where needed, and widely deployed in local communities.

In this Health Policy paper, we review potential challenges to success in each of these dimensions and discuss policy implications. To guide our review, we developed a dashboard to highlight key characteristics of 26 leading vaccine candidates, including efficacy levels, dosing regimens, storage requirements, prices, production capacities in 2021, and stocks reserved for low-income and middle-income countries. We use a traffic-light system to signal the potential contributions of each candidate to achieving global vaccine immunity, highlighting important trade-offs that policy makers need to consider when developing and implementing vaccination programmes. ...

Country / Region Tags:

General Topic Tags: